Clustering data with heatmap algorithm for Metabolomic profiles in healthy research cats receiving clindamycin with a synbiotic or a placebo: a randomized, controlled trial (Study ST000979)

This analysis uses the 'heatmap.2' function of gplots package in the R statistics environment


The rows are scaled to have mean=0 and standard deviation=1

Factors:

F1Group:NA | Timepoint:NA | Gender:NA | Age at start of study:-
F2Group:Placebo | Timepoint:Baseline (days 5-7) | Gender:Female spayed | Age at start of study:3
F3Group:Placebo | Timepoint:Baseline (days 5-7) | Gender:Female spayed | Age at start of study:6
F4Group:Placebo | Timepoint:Baseline (days 5-7) | Gender:Female spayed | Age at start of study:7
F5Group:Placebo | Timepoint:Baseline (days 5-7) | Gender:Female spayed | Age at start of study:8
F6Group:Placebo | Timepoint:Baseline (days 5-7) | Gender:Male castrated | Age at start of study:5
F7Group:Placebo | Timepoint:Baseline (days 5-7) | Gender:Male castrated | Age at start of study:6
F8Group:Placebo | Timepoint:Completion of treatment (days 26-28) | Gender:Female spayed | Age at start of study:3
F9Group:Placebo | Timepoint:Completion of treatment (days 26-28) | Gender:Female spayed | Age at start of study:6
F10Group:Placebo | Timepoint:Completion of treatment (days 26-28) | Gender:Female spayed | Age at start of study:7
F11Group:Placebo | Timepoint:Completion of treatment (days 26-28) | Gender:Female spayed | Age at start of study:8
F12Group:Placebo | Timepoint:Completion of treatment (days 26-28) | Gender:Male castrated | Age at start of study:5
F13Group:Placebo | Timepoint:Completion of treatment (days 26-28) | Gender:Male castrated | Age at start of study:6
F14Group:Placebo | Timepoint:Recovery (days 631-633) | Gender:Female spayed | Age at start of study:3
F15Group:Placebo | Timepoint:Recovery (days 631-633) | Gender:Female spayed | Age at start of study:6
F16Group:Placebo | Timepoint:Recovery (days 631-633) | Gender:Female spayed | Age at start of study:7
F17Group:Placebo | Timepoint:Recovery (days 631-633) | Gender:Female spayed | Age at start of study:8
F18Group:Placebo | Timepoint:Recovery (days 631-633) | Gender:Male castrated | Age at start of study:5
F19Group:Placebo | Timepoint:Recovery (days 631-633) | Gender:Male castrated | Age at start of study:6
F20Group:Synbiotic | Timepoint:Baseline (days 5-7) | Gender:Female spayed | Age at start of study:3
F21Group:Synbiotic | Timepoint:Baseline (days 5-7) | Gender:Female spayed | Age at start of study:6
F22Group:Synbiotic | Timepoint:Baseline (days 5-7) | Gender:Female spayed | Age at start of study:8
F23Group:Synbiotic | Timepoint:Baseline (days 5-7) | Gender:Male castrated | Age at start of study:3
F24Group:Synbiotic | Timepoint:Baseline (days 5-7) | Gender:Male castrated | Age at start of study:5
F25Group:Synbiotic | Timepoint:Baseline (days 5-7) | Gender:Male castrated | Age at start of study:6
F26Group:Synbiotic | Timepoint:Completion of treatment (days 26-28) | Gender:Female spayed | Age at start of study:3
F27Group:Synbiotic | Timepoint:Completion of treatment (days 26-28) | Gender:Female spayed | Age at start of study:6
F28Group:Synbiotic | Timepoint:Completion of treatment (days 26-28) | Gender:Female spayed | Age at start of study:8
F29Group:Synbiotic | Timepoint:Completion of treatment (days 26-28) | Gender:Male castrated | Age at start of study:3
F30Group:Synbiotic | Timepoint:Completion of treatment (days 26-28) | Gender:Male castrated | Age at start of study:5
F31Group:Synbiotic | Timepoint:Completion of treatment (days 26-28) | Gender:Male castrated | Age at start of study:6
F32Group:Synbiotic | Timepoint:Recovery (days 631-633) | Gender:Female spayed | Age at start of study:3
F33Group:Synbiotic | Timepoint:Recovery (days 631-633) | Gender:Female spayed | Age at start of study:6
F34Group:Synbiotic | Timepoint:Recovery (days 631-633) | Gender:Female spayed | Age at start of study:8
F35Group:Synbiotic | Timepoint:Recovery (days 631-633) | Gender:Male castrated | Age at start of study:3
F36Group:Synbiotic | Timepoint:Recovery (days 631-633) | Gender:Male castrated | Age at start of study:5
F37Group:Synbiotic | Timepoint:Recovery (days 631-633) | Gender:Male castrated | Age at start of study:6
Data matrix
  logo